Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis: Prostate/GU

Impact of fluorocholine(18F) PET/CT in case of occult recurrence of prostate cancer

Jean-Noel Talbot, Virginie Huchet, Caroline Rousseau, Alexandre Cochet, Pierre Olivier, Frederic Courbon, Herve Foehrenbach and Valerie Nataf
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1911;
Jean-Noel Talbot
1Medecine Nucleaire, Hopital Tenon AP-HP & UPMC, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginie Huchet
1Medecine Nucleaire, Hopital Tenon AP-HP & UPMC, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline Rousseau
2ICHOROPRO team, Ap, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandre Cochet
2ICHOROPRO team, Ap, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Olivier
2ICHOROPRO team, Ap, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederic Courbon
2ICHOROPRO team, Ap, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Herve Foehrenbach
2ICHOROPRO team, Ap, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valerie Nataf
1Medecine Nucleaire, Hopital Tenon AP-HP & UPMC, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 52 no. supplement 1 1911

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2011

Author Information

  1. Jean-Noel Talbot1,
  2. Virginie Huchet1,
  3. Caroline Rousseau2,
  4. Alexandre Cochet2,
  5. Pierre Olivier2,
  6. Frederic Courbon2,
  7. Herve Foehrenbach2 and
  8. Valerie Nataf1
  1. 1Medecine Nucleaire, Hopital Tenon AP-HP & UPMC, Paris, France
  2. 2ICHOROPRO team, Ap, France

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2014 to April 2025

AbstractFullPdf
Dec 2014100
Jan 2015200
Apr 2015100
Jun 2015200
Jul 2015500
Sep 2015800
Nov 2015200
Dec 2015700
Jan 2016100
Mar 2016100
Apr 2016400
May 2016500
Jun 2016100
Jul 2016400
Nov 2016100
Dec 2016100
Feb 2017200
Mar 2017100
Apr 2017100
May 2017300
Jun 2017400
Jul 2017400
Aug 2017400
Sep 20171500
Nov 2017200
Feb 2018500
Mar 2018100
May 2018200
Jun 2018100
Sep 2018500
Oct 2018200
Dec 2018300
Oct 2019200
Nov 2019100
Feb 2020400
Mar 20201700
Apr 2020900
Jul 2020100
Aug 2020400
Sep 20201800
Oct 20201400
Nov 20201000
Dec 2020700
Jan 2021300
Feb 2021800
Mar 2021500
Apr 2021700
May 20212500
Jun 2021700
Jul 20211500
Aug 20212700
Sep 2021800
Oct 2021800
Nov 20215300
Dec 20212100
Jan 20224900
Feb 20221500
Mar 20222800
Apr 20222100
May 20222000
Jun 2022100
Aug 2022100
Nov 2022100
Dec 2022100
Jan 2023200
Feb 2023200
Mar 2023100
Apr 2023100
May 2023100
Jun 2023100
Jul 2023300
Aug 2023400
Sep 2023100
Oct 2023100
Nov 2023100
Dec 2023400
Jan 2024300
Mar 2024300
Apr 2024100
May 2024300
Jun 2024200
Aug 2024700
Sep 2024400
Oct 2024900
Nov 2024200
Dec 2024300
Jan 2025300
Mar 2025200
Apr 2025600
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of fluorocholine(18F) PET/CT in case of occult recurrence of prostate cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Impact of fluorocholine(18F) PET/CT in case of occult recurrence of prostate cancer
Jean-Noel Talbot, Virginie Huchet, Caroline Rousseau, Alexandre Cochet, Pierre Olivier, Frederic Courbon, Herve Foehrenbach, Valerie Nataf
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1911;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Impact of fluorocholine(18F) PET/CT in case of occult recurrence of prostate cancer
Jean-Noel Talbot, Virginie Huchet, Caroline Rousseau, Alexandre Cochet, Pierre Olivier, Frederic Courbon, Herve Foehrenbach, Valerie Nataf
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1911;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis: Prostate/GU

  • Early dynamic PET/CT and 18F-FDG blood flow imaging in bladder cancer detection: A novel approach
  • Whole body human biodistribution of the PSMA inhibitor [18F]DCFBC
  • Chemotherapy associated changes in metastatic tumor 18F-fluorocholine uptake and circulating DNA levels in hormone-refractory prostate cancer
Show more Oncology: Clinical Diagnosis: Prostate/GU

Prostate-GU Posters

  • Early dynamic PET/CT and 18F-FDG blood flow imaging in bladder cancer detection: A novel approach
  • Whole body human biodistribution of the PSMA inhibitor [18F]DCFBC
  • Chemotherapy associated changes in metastatic tumor 18F-fluorocholine uptake and circulating DNA levels in hormone-refractory prostate cancer
Show more Prostate-GU Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire